The organizers of the Swedish-American Life Science
Summit today announced the final details on the Life Science Summit,
which takes place in Stockholm, Sweden on August 17th and 18th.
Ms.Barbro Ehnbom, Chairman of the Swedish-American Life Science Summit issued the following statement: "We are delighted to be able to invite some of the worlds most influential Life Science investors back to this second Swedish-American Life Science Summit. Building on the tremendous success of last year, this year we expect even more interesting insights and exciting announcements of both new biotechnology breakthroughs and successful investment transactions. I am particularly happy that last year's keynote speaker, Mr. Frederick Frank, Vice Chairman of Lehman Brothers and a legend in the Life Science Industry, has agreed to become the Official Advisor to the Swedish-American Life Science Summit".
The Summit will take place at the headquarters of the Kreab Group and will be moderated by Mr. Udayan Gupta, former Venture Capital Editor for the Wall Street Journal. It will offer a broad view analysis of Swedish-American Life Science investments, covering both companies and technologies, and focusing in particular on changes in international investment strategies and collaboration methods. Confirmed speakers include:
Dr. William Haseltine, Founder and Chairman of Human Genome Sciences; Mr. Jay Lobell, President of Paramount BioCapital; Senator Larry Pressler (Ret.); Mr. William Gedale, Managing General Partner, NGN Capital; Dr. Yuval Binur, General Partner, Accelerated Technologies; Dr. Laurent Leksell, Founder and Director, Elekta AB; Professor Matthias Uhlen, KTH Biotechnology and Professor Hans Wigzell, Scientific Advisor to the Swedish Government, Mr. Peter Ehrenheim, CEO, GE Healthcare Life Science; Niklas Prager, CEO, Pfizer AB.
The Summit is supported by Prime Minister Goran Persson, who in his welcoming letter to the delegates writes: "Just as I did last year, I welcome this Summit as a great initiative, strengthening the cooperation between the largest market in the world, the United States, and one of the most vibrant research regions, Sweden." About the Summit
The Swedish-American Life Science Summit 2006 is the second in a series of annual summer summits in Stockholm. It is an invitation-only event that features world-leading Life Science executives, researchers and investors. The summit serves as a unique meeting point for select decision makers from both the United States and Sweden.
Detailed information about the Swedish-American Life Science Summit can be found at www.swedishamericanlifescience.com. This information was brought to you by Waymaker: http://www.waymaker.net
Ms.Barbro Ehnbom, Chairman of the Swedish-American Life Science Summit issued the following statement: "We are delighted to be able to invite some of the worlds most influential Life Science investors back to this second Swedish-American Life Science Summit. Building on the tremendous success of last year, this year we expect even more interesting insights and exciting announcements of both new biotechnology breakthroughs and successful investment transactions. I am particularly happy that last year's keynote speaker, Mr. Frederick Frank, Vice Chairman of Lehman Brothers and a legend in the Life Science Industry, has agreed to become the Official Advisor to the Swedish-American Life Science Summit".
The Summit will take place at the headquarters of the Kreab Group and will be moderated by Mr. Udayan Gupta, former Venture Capital Editor for the Wall Street Journal. It will offer a broad view analysis of Swedish-American Life Science investments, covering both companies and technologies, and focusing in particular on changes in international investment strategies and collaboration methods. Confirmed speakers include:
Dr. William Haseltine, Founder and Chairman of Human Genome Sciences; Mr. Jay Lobell, President of Paramount BioCapital; Senator Larry Pressler (Ret.); Mr. William Gedale, Managing General Partner, NGN Capital; Dr. Yuval Binur, General Partner, Accelerated Technologies; Dr. Laurent Leksell, Founder and Director, Elekta AB; Professor Matthias Uhlen, KTH Biotechnology and Professor Hans Wigzell, Scientific Advisor to the Swedish Government, Mr. Peter Ehrenheim, CEO, GE Healthcare Life Science; Niklas Prager, CEO, Pfizer AB.
The Summit is supported by Prime Minister Goran Persson, who in his welcoming letter to the delegates writes: "Just as I did last year, I welcome this Summit as a great initiative, strengthening the cooperation between the largest market in the world, the United States, and one of the most vibrant research regions, Sweden." About the Summit
The Swedish-American Life Science Summit 2006 is the second in a series of annual summer summits in Stockholm. It is an invitation-only event that features world-leading Life Science executives, researchers and investors. The summit serves as a unique meeting point for select decision makers from both the United States and Sweden.
Detailed information about the Swedish-American Life Science Summit can be found at www.swedishamericanlifescience.com. This information was brought to you by Waymaker: http://www.waymaker.net
© 2006 Business Wire